首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

2126447

全球去心房顫動市場：策略分析與預測（2026-2031年）

Global Defibrillators Market - Strategic Insights and Forecasts (2026-2031)

出版日期: 2026年08月13日 | 出版商:

Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球去心房顫動市場預計將以 5.0% 的複合年成長率成長，從 2026 年的 181.4 億美元成長到 2031 年的 231 億美元。

全球去心房顫動市場正經歷重大變革，其驅動力包括：互聯心臟護理模式轉移、公共去心房顫動計畫的擴展以及遠端患者監護的整合。這一市場演變的特點在於，人們意識到快速干預心室心律不整對於生存至關重要，這使得去心房顫動技術在醫院、急診室和社區中不可或缺。先進的植入式醫療設備、自動體外心臟去心房顫動(AED) 和數位健康平台的融合，使得心臟麻痹的管理更加快速、便捷，並日益依賴數據驅動。根據世界衛生組織 (WHO) 統計，每年約有 1,790 萬人死於心血管疾病，且心血管疾病的盛行率不斷上升，因此醫療系統正在擴大篩檢、監測和預防性治療計畫。對遠端監測能力、設備小型化和演算法開發的大量投資，正推動去心房顫動成為現代心臟醫學的基石。

市場促進因素

心律不整和心臟麻痹負擔日益加重，是全球去心房顫動市場的主要驅動力。臨床證據不斷強調快速介入室心室心律不整的重要性。隨著心血管疾病盛行率的上升，醫療系統正在擴大篩檢、監測和預防性治療計畫。供應商受益於早期患者檢出率的提高、轉診率的上升以及植入式去心房顫動技術在高風險人群中的更廣泛應用，從而推動了去心房顫動使用量的持續成長。公共去心房顫動舉措的推廣進一步加速了市場成長，增加了自動體外去顫器（AED）的安裝量。政府、緊急應變機構、機場、體育設施、教育機構和雇主都在擴大AED的安裝量，以提高院外心臟麻痹患者的存活率。採購決策越來越傾向於選擇使用者訓練需求低、能夠在緊急情況下提供自動指導的系統。製造商正在透過簡化設備介面和擴展服務支援計劃來應對這一需求。遠端患者監護的進步正在增強其臨床提案，並有助於創造持續的業務收益機會。醫療服務提供者正在尋求能夠減少不必要的住院次數並改善患者長期管理的醫療技術。現代ICD平台擴大整合了無線監護、雲端資料傳輸和醫生警報等功能。這些功能提升了臨床價值，並有助於創造持續的業務收益機會。心血管疾病治療領域不斷成長的醫療支出推動了對去心房顫動技術的持續投資。心臟病仍然是已開發國家和新興國家醫療投資的重點領域。醫院持續投資於電生理檢查室、心臟外科手術設施、加護病房和心律不整管理專科計畫。

市場限制因素

植入式系統高昂的總治療費用是其普及應用的一大障礙。植入式心臟整流去顫器(ICD) 需要購買設備、進行植入手術、依賴醫生的專業技術、進行後續護理以及定期更換。嚴格的監管和上市後監測要求增加了研發成本，並延長了產品核可時間。由於去心房顫動承擔著維持生命的重要功能，因此其運作受到嚴格法規環境。設備召回和產品可靠性問題會導致監測成本增加、影響醫生信心，並給供應商帶來聲譽風險。某些市場中專科醫師數量有限，即使患者需求旺盛，也可能限制手術量。隨著遠端監測技術的日益成熟，網路安全和資料管理方面的要求也增加了研發的複雜性和營運成本。

北美洲
- 按類型
- 最終用戶
- 國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 按類型
- 最終用戶
- 國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 按類型
- 最終用戶
- 國家
  - 德國
  - 法國
  - 英國
  - 義大利
  - 西班牙
  - 其他
中東和非洲
- 按類型
- 最終用戶
- 國家
  - 沙烏地阿拉伯
  - 以色列
  - 阿拉伯聯合大公國
  - 其他
亞太地區
- 按類型
- 最終用戶
- 國家
  - 中國
  - 日本
  - 韓國
  - 印度
  - 澳洲
  - 印尼
  - 泰國
  - 台灣
  - 其他

第8章：競爭環境與分析

主要公司及策略分析
市佔率分析
企業合併、合約、合作關係
競爭環境儀錶板

第9章：公司簡介

Boston Scientific Corporation
Medtronic
ZOLL Medical Corporation
AbbottAbott
Defibtech LLC
Koninklijke Philips NV
Nihon Kohden Corporation
Schiller AG
Stryker Corporation
Bexen Cardio

簡介目錄

Product Code: KSI061611897

The Global Defibrillators market is forecast to grow at a CAGR of 5.0%, reaching USD 23.10 billion in 2031 from USD 18.14 billion in 2026.

The global defibrillators market is undergoing significant transformation driven by the paradigm shift toward connected cardiac care, the expansion of public-access defibrillation programs, and the growing integration of remote patient monitoring. The market's evolution is characterized by the recognition that rapid intervention for ventricular arrhythmias is critical for survival, making defibrillation technologies essential across hospital, emergency, and community settings. The convergence of advanced implantable devices, automated external defibrillators, and digital health platforms is enabling faster, more accessible, and increasingly data-driven cardiac arrest management. Healthcare systems are expanding screening, monitoring, and preventive treatment programs as cardiovascular disease prevalence rises, with the World Health Organization reporting approximately 17.9 million annual deaths from cardiovascular diseases. The market is witnessing significant investment in remote monitoring capabilities, device miniaturization, and algorithm development, positioning defibrillators as a cornerstone of modern cardiac care.

Market Drivers

The growing burden of cardiac arrhythmias and sudden cardiac arrest represents the primary driver for the global defibrillators market. Clinical evidence continues to demonstrate the importance of rapid intervention for ventricular arrhythmias. Healthcare systems are expanding screening, monitoring, and preventive treatment programs as cardiovascular disease prevalence rises. Suppliers benefit from increased patient identification, higher referral volumes, and broader use of implantable defibrillation technologies among high-risk populations, resulting in sustained growth in defibrillator utilization. The expansion of public-access defibrillation initiatives is further accelerating market growth through increased AED deployment. Governments, emergency response agencies, airports, sports venues, educational institutions, and employers are increasing AED deployment to improve survival outcomes following out-of-hospital cardiac arrest. Procurement decisions increasingly favor systems that require limited user training and provide automated guidance during emergencies. Manufacturers have responded by simplifying device interfaces and expanding service support programs. Advances in remote patient monitoring are strengthening clinical value propositions and contributing to recurring service revenue opportunities. Healthcare providers are seeking technologies that improve long-term patient management while reducing unnecessary hospital visits. Modern ICD platforms increasingly incorporate wireless monitoring, cloud-based data transmission, and physician alert capabilities. These features strengthen clinical value propositions and contribute to recurring service revenue opportunities. The expansion of healthcare expenditure in cardiovascular care is supporting sustained investment in defibrillation technologies. Cardiac disease remains a priority area for healthcare investment across developed and emerging economies. Hospitals continue to invest in electrophysiology laboratories, cardiac surgery facilities, intensive care units, and specialized arrhythmia management programs.

Market Restraints

High total treatment costs associated with implantable systems create access barriers. Implantable cardioverter-defibrillators require device acquisition, implantation procedures, physician expertise, follow-up care, and periodic replacement. Stringent regulatory and post-market surveillance requirements increase development costs and extend product approval timelines. Defibrillators operate in a highly regulated environment due to their life-sustaining function. Device recalls and product reliability concerns can increase monitoring costs, affect physician confidence, and create reputational risks for suppliers. Limited specialist availability in certain markets can restrict procedure volumes even when patient demand exists. Cybersecurity and data management requirements increase development complexity and operating costs as remote monitoring capabilities become more sophisticated.

Technology and Product Insights

The technology landscape is characterized by the growing importance of connected devices, remote monitoring, and digital health integration. ICDs represent the most commercially important segment because they are designed to continuously monitor cardiac rhythm and deliver corrective therapy when life-threatening arrhythmias are detected. Their clinical importance, combined with relatively high average selling prices and long-term patient management requirements, makes the segment a major source of industry revenue. Demand is strongly linked to the management of patients with heart failure, previous cardiac arrest events, inherited arrhythmia syndromes, and other conditions associated with elevated sudden cardiac death risk. Clinical guidelines and reimbursement frameworks in developed healthcare systems continue to support ICD utilization among eligible patient groups. AEDs serve hospitals, emergency medical services, workplaces, educational institutions, transportation hubs, and community settings. WCDs address temporary protection requirements for patients who face elevated cardiac risk but may not yet qualify for permanent implantation. The segment analysis reveals that hospitals and cardiac care centers prioritize clinical performance, device reliability, battery longevity, integration with monitoring systems, and physician familiarity. Public-access defibrillation programs focus on ease of use, training requirements, maintenance costs, and regulatory compliance. North America represents one of the most developed defibrillator markets globally, with strong reimbursement frameworks, extensive electrophysiology capacity, established emergency response systems, and widespread physician familiarity. Europe remains important due to established cardiac care networks and ageing populations. Asia Pacific presents significant growth opportunities as cardiovascular disease incidence, healthcare infrastructure investment, and awareness of sudden cardiac arrest increase. The integration of digital health is becoming increasingly important as manufacturers generate recurring revenue through device monitoring services, replacement procedures, maintenance contracts, software updates, consumables, and clinical support programs.

Competitive and Strategic Outlook

The competitive environment combines multinational cardiovascular device manufacturers with specialized defibrillation suppliers, with competition influenced by clinical evidence, physician relationships, regulatory compliance capabilities, service infrastructure, product reliability, and digital monitoring functionality. Medtronic and Boston Scientific Corporation maintain strong positions within implantable defibrillation technologies through extensive electrophysiology portfolios, broad clinical evidence bases, and global distribution networks, with competition frequently centering on device performance, monitoring capabilities, battery longevity, and physician preference. Abbott continues to strengthen its cardiovascular device portfolio through integrated cardiac rhythm management offerings, with product differentiation increasingly depending on data management capabilities and long-term patient monitoring support. ZOLL Medical Corporation, Stryker Corporation, Koninklijke Philips N.V., and Defibtech LLC maintain strong positions within external defibrillation markets, where competition is influenced by ease of use, training requirements, durability, maintenance support, and deployment flexibility. Nihon Kohden Corporation, Schiller AG, and Bexen Cardio compete through specialized product portfolios, regional presence, and targeted customer relationships. Barriers to entry remain relatively high, with new participants facing regulatory requirements, clinical validation costs, quality management obligations, physician adoption challenges, and established supplier relationships. Recent key developments include Medtronic receiving FDA approval for the OmniaSecure defibrillation lead supporting left bundle branch area pacing. HeartHero submitted an FDA Premarket Approval application for Elliot AED, a connected automated external defibrillator designed specifically for home and community cardiac emergency response. BIOTRONIK launched the Acticor Sky and Rivacor Sky ICD/CRT-D family, the first CE-approved conduction-system pacing defibrillators. ZOLL Medical announced EU MDR approval for its Zenix monitor/defibrillator. Kestra Medical Technologies partnered with Biobeat Technologies to expand diagnostic monitoring capabilities for ASSURE wearable cardioverter defibrillator patients. AliveCor received FDA clearance expanding Kardia 12L ECG System capabilities with five additional AI-powered cardiac determinations.

Short Conclusion

The global defibrillators market is positioned for sustained growth driven by the convergence of cardiovascular disease burden, technological innovation, and expanding access to care. The transition from standalone devices toward integrated cardiac rhythm management ecosystems represents a fundamental shift in cardiac care. While challenges related to high costs, regulatory complexity, and specialist availability persist, strategic investments in technology, clinical evidence, and digital connectivity are creating durable competitive advantages for market leaders. The long-term market outlook remains positive, with defibrillators evolving into a cornerstone of modern cardiac care, supporting arrhythmia management, sudden cardiac arrest response, and improved patient outcomes across global healthcare systems.

Key Benefits of this Report

Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2031
Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
Competitive positioning, strategies, and market share evaluation, and trade analysis
Revenue growth and forecast assessment across segments and regions
Company profiling including strategies, products, financials, and key developments

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View

5. GLOBAL DEFIBRILLATORS MARKET BY TYPE

5.1. Introduction
5.2. Automated External Defibrillator (AED)
- 5.2.1. Market Opportunities and Trends
- 5.2.2. Growth Prospects
- 5.2.3. Geographic Lucrativeness
5.3. Implantable Cardioverter-Defibrillator (ICD)
- 5.3.1. Market Opportunities and Trends
- 5.3.2. Growth Prospects
- 5.3.3. Geographic Lucrativeness
5.4. Wearable Cardio Defibrillator (WCD)
- 5.4.1. Market Opportunities and Trends
- 5.4.2. Growth Prospects
- 5.4.3. Geographic Lucrativeness

6. GLOBAL DEFIBRILLATORS MARKET BY END-USER

6.1. Introduction
6.2. Hospitals and Clinics
- 6.2.1. Market Opportunities and Trends
- 6.2.2. Growth Prospects
- 6.2.3. Geographic Lucrativeness
6.3. Ambulatory Surgical Center
- 6.3.1. Market Opportunities and Trends
- 6.3.2. Growth Prospects
- 6.3.3. Geographic Lucrativeness
6.4. Others
- 6.4.1. Market Opportunities and Trends
- 6.4.2. Growth Prospects
- 6.4.3. Geographic Lucrativeness

7. GLOBAL DEFIBRILLATORS MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. By Type
- 7.2.2. By End-User
- 7.2.3. By Country
  - 7.2.3.1. USA
    - 7.2.3.1.1. Market Opportunities and Trends
    - 7.2.3.1.2. Growth Prospects
  - 7.2.3.2. Canada
    - 7.2.3.2.1. Market Opportunities and Trends
    - 7.2.3.2.2. Growth Prospects
  - 7.2.3.3. Mexico
    - 7.2.3.3.1. Market Opportunities and Trends
    - 7.2.3.3.2. Growth Prospects
7.3. South America
- 7.3.1. By Type
- 7.3.2. By End-User
- 7.3.3. By Country
  - 7.3.3.1. Brazil
    - 7.3.3.1.1. Market Opportunities and Trends
    - 7.3.3.1.2. Growth Prospects
  - 7.3.3.2. Argentina
    - 7.3.3.2.1. Market Opportunities and Trends
    - 7.3.3.2.2. Growth Prospects
  - 7.3.3.3. Others
    - 7.3.3.3.1. Market Opportunities and Trends
    - 7.3.3.3.2. Growth Prospects
7.4. Europe
- 7.4.1. By Type
- 7.4.2. By End-User
- 7.4.3. By Country
  - 7.4.3.1. Germany
    - 7.4.3.1.1. Market Opportunities and Trends
    - 7.4.3.1.2. Growth Prospects
  - 7.4.3.2. France
    - 7.4.3.2.1. Market Opportunities and Trends
    - 7.4.3.2.2. Growth Prospects
  - 7.4.3.3. United Kingdom
    - 7.4.3.3.1. Market Opportunities and Trends
    - 7.4.3.3.2. Growth Prospects
  - 7.4.3.4. Italy
    - 7.4.3.4.1. Market Opportunities and Trends
    - 7.4.3.4.2. Growth Prospects
  - 7.4.3.5. Spain
    - 7.4.3.5.1. Market Opportunities and Trends
    - 7.4.3.5.2. Growth Prospects
  - 7.4.3.6. Others
    - 7.4.3.6.1. Market Opportunities and Trends
    - 7.4.3.6.2. Growth Prospects
7.5. Middle East and Africa
- 7.5.1. By Type
- 7.5.2. By End-User
- 7.5.3. By Country
  - 7.5.3.1. Saudi Arabia
    - 7.5.3.1.1. Market Opportunities and Trends
    - 7.5.3.1.2. Growth Prospects
  - 7.5.3.2. Israel
    - 7.5.3.2.1. Market Opportunities and Trends
    - 7.5.3.2.2. Growth Prospects
  - 7.5.3.3. United Arab Emirates
    - 7.5.3.3.1. Market Opportunities and Trends
    - 7.5.3.3.2. Growth Prospects
  - 7.5.3.4. Others
    - 7.5.3.4.1. Market Opportunities and Trends
    - 7.5.3.4.2. Growth Prospects
7.6. Asia Pacific
- 7.6.1. By Type
- 7.6.2. By End-User
- 7.6.3. By Country
  - 7.6.3.1. China
    - 7.6.3.1.1. Market Opportunities and Trends
    - 7.6.3.1.2. Growth Prospects
  - 7.6.3.2. Japan
    - 7.6.3.2.1. Market Opportunities and Trends
    - 7.6.3.2.2. Growth Prospects
  - 7.6.3.3. South Korea
    - 7.6.3.3.1. Market Opportunities and Trends
    - 7.6.3.3.2. Growth Prospects
  - 7.6.3.4. India
    - 7.6.3.4.1. Market Opportunities and Trends
    - 7.6.3.4.2. Growth Prospects
  - 7.6.3.5. Australia
    - 7.6.3.5.1. Market Opportunities and Trends
    - 7.6.3.5.2. Growth Prospects
  - 7.6.3.6. Indonesia
    - 7.6.3.6.1. Market Opportunities and Trends
    - 7.6.3.6.2. Growth Prospects
  - 7.6.3.7. Thailand
    - 7.6.3.7.1. Market Opportunities and Trends
    - 7.6.3.7.2. Growth Prospects
  - 7.6.3.8. Taiwan
    - 7.6.3.8.1. Market Opportunities and Trends
    - 7.6.3.8.2. Growth Prospects
  - 7.6.3.9. Others
    - 7.6.3.9.1. Market Opportunities and Trends
    - 7.6.3.9.2. Growth Prospects